Literature DB >> 28852924

USP10 inhibits lung cancer cell growth and invasion by upregulating PTEN.

Jia Sun1, Tianxiang Li1, Yinying Zhao1, Lirong Huang1, Hua Sun1, Hui Wu1, Xiufeng Jiang2.   

Abstract

To determine the potential tumor suppressor functions of ubiquitin-specific protease 10 (USP10) in lung cancer and elucidate underlying molecular mechanism. The relative expression of USP10 was determined by real-time PCR and immunoblotting. The inhibitory effect of USP10 on tumor growth was demonstrated on allograft mice with Lewis carcinoma cell inoculation. The relative cell proliferation was measured with Cell Counting Kit-8 (CCK-8). The invasive capacity was evaluated by transwell assay. The interaction between USP10 and Phosphatase And Tensin Homolog (PTEN) was examined by co-immunoprecipitation. Ubiquitination/deubiquitination was analyzed by immunoprecipitation followed by immunoblotting. USP10 was down-regulated in lung cancer. Knockdown of USP10 promotes tumor growth and invasion both in vitro and in vivo. We further demonstrated that USP10 directly interacted with and stabilized PTEN via deubiquitination. The pro-cancerous effect of USP10 deficiency was abolished by re-introduction of PTEN. We suggested a tumor suppressor function of USP10 in lung cancer via deubiquitinating and stabilizing PTEN.

Entities:  

Keywords:  Invasion; Lung cancer; PTEN; USP10; Ubiquitination

Mesh:

Substances:

Year:  2017        PMID: 28852924     DOI: 10.1007/s11010-017-3170-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

Review 1.  Lung cancer epidemiology, risk factors, and prevention.

Authors:  Patricia de Groot; Reginald F Munden
Journal:  Radiol Clin North Am       Date:  2012-09       Impact factor: 2.303

2.  Deubiquitination and stabilization of T-bet by USP10.

Authors:  Lina Pan; Zuojia Chen; Linlin Wang; Chen Chen; Dan Li; Huanying Wan; Bin Li; Guochao Shi
Journal:  Biochem Biophys Res Commun       Date:  2014-05-17       Impact factor: 3.575

3.  NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN.

Authors:  Xinjiang Wang; Lloyd C Trotman; Theresa Koppie; Andrea Alimonti; Zhenbang Chen; Zhonghua Gao; Junru Wang; Hediye Erdjument-Bromage; Paul Tempst; Carlos Cordon-Cardo; Pier Paolo Pandolfi; Xuejun Jiang
Journal:  Cell       Date:  2007-01-12       Impact factor: 41.582

4.  The deubiquitinating enzyme USP10 regulates the endocytic recycling of CFTR in airway epithelial cells.

Authors:  Jennifer M Bomberger; Roxanna L Barnaby; Bruce A Stanton
Journal:  Channels (Austin)       Date:  2010 May-Jun       Impact factor: 2.581

5.  Ubiquitin-specific Peptidase 10 (USP10) Deubiquitinates and Stabilizes MutS Homolog 2 (MSH2) to Regulate Cellular Sensitivity to DNA Damage.

Authors:  Mu Zhang; Chen Hu; Dan Tong; Shengyan Xiang; Kendra Williams; Wenlong Bai; Guo-Min Li; Gerold Bepler; Xiaohong Zhang
Journal:  J Biol Chem       Date:  2016-03-14       Impact factor: 5.157

Review 6.  PTEN and the PI3-kinase pathway in cancer.

Authors:  Nader Chalhoub; Suzanne J Baker
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

7.  USP10 regulates p53 localization and stability by deubiquitinating p53.

Authors:  Jian Yuan; Kuntian Luo; Lizhi Zhang; John C Cheville; Zhenkun Lou
Journal:  Cell       Date:  2010-01-21       Impact factor: 41.582

Review 8.  The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications.

Authors:  Amancio Carnero; Carmen Blanco-Aparicio; Oliver Renner; Wolfgang Link; Juan F M Leal
Journal:  Curr Cancer Drug Targets       Date:  2008-05       Impact factor: 3.428

9.  Rak functions as a tumor suppressor by regulating PTEN protein stability and function.

Authors:  Eun-Kyoung Yim; Guang Peng; Hui Dai; Ruozhen Hu; Kaiyi Li; Yiling Lu; Gordon B Mills; Funda Meric-Bernstam; Bryan T Hennessy; Rolf J Craven; Shiaw-Yih Lin
Journal:  Cancer Cell       Date:  2009-04-07       Impact factor: 31.743

10.  MicroRNA-191 promotes pancreatic cancer progression by targeting USP10.

Authors:  Hua Liu; Xuan-Fu Xu; Yan Zhao; Mao-Chun Tang; Ying-Qun Zhou; Jie Lu; Feng-Hou Gao
Journal:  Tumour Biol       Date:  2014-08-29
View more
  19 in total

1.  An integrative pan-cancer analysis of biological and clinical impacts underlying ubiquitin-specific-processing proteases.

Authors:  Di Chen; Zhen Ning; Huan Chen; Chang Lu; Xiaolong Liu; Tian Xia; Huan Qi; Wen Wang; Ting Ling; Xin Guo; Dinesh Singh Tekcham; Xiumei Liu; Jing Liu; Aman Wang; Qiu Yan; Ji-Wei Liu; Guang Tan; Hai-Long Piao
Journal:  Oncogene       Date:  2019-09-11       Impact factor: 9.867

2.  Loss of Both USP10 and p14ARF Protein Expression Is an Independent Prognostic Biomarker for Poor Prognosis in Patients With Epithelial Ovarian Cancer.

Authors:  Gwan Hee Han; Doo Byung Chay; Joo Mi Yi; Hanbyoul Cho; Joon-Yong Chung; Jae-Hoon Kim
Journal:  Cancer Genomics Proteomics       Date:  2019 Nov-Dec       Impact factor: 4.069

Review 3.  Pro-apoptotic and anti-apoptotic regulation mediated by deubiquitinating enzymes.

Authors:  Hae-Seul Choi; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2022-02-03       Impact factor: 9.261

Review 4.  Posttranslational Regulation and Conformational Plasticity of PTEN.

Authors:  Larissa Kotelevets; Barbara Trifault; Eric Chastre; Mark G H Scott
Journal:  Cold Spring Harb Perspect Med       Date:  2020-07-01       Impact factor: 5.159

Review 5.  Inhibition of Ubiquitin-Specific Proteases as a Novel Anticancer Therapeutic Strategy.

Authors:  Tao Yuan; Fangjie Yan; Meidan Ying; Ji Cao; Qiaojun He; Hong Zhu; Bo Yang
Journal:  Front Pharmacol       Date:  2018-09-27       Impact factor: 5.810

6.  Deubiquitinating enzyme USP10 promotes hepatocellular carcinoma metastasis through deubiquitinating and stabilizing Smad4 protein.

Authors:  Tao Yuan; Zibo Chen; Fangjie Yan; Meijia Qian; Hong Luo; Song Ye; Ji Cao; Meidan Ying; Xiaoyang Dai; Renhua Gai; Bo Yang; Qiaojun He; Hong Zhu
Journal:  Mol Oncol       Date:  2019-11-27       Impact factor: 6.603

Review 7.  Revisiting the Concept of Stress in the Prognosis of Solid Tumors: A Role for Stress Granules Proteins?

Authors:  Anaïs Aulas; Pascal Finetti; Shawn M Lyons; François Bertucci; Daniel Birnbaum; Claire Acquaviva; Emilie Mamessier
Journal:  Cancers (Basel)       Date:  2020-09-01       Impact factor: 6.639

8.  The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53.

Authors:  Chen Hu; Mu Zhang; Niko Moses; Cong-Li Hu; Lisa Polin; Wei Chen; Hyejeong Jang; Joshua Heyza; Agnes Malysa; Joseph A Caruso; Shengyan Xiang; Steve Patrick; Paul Stemmer; Zhenkun Lou; Wenlong Bai; Chuangui Wang; Gerold Bepler; Xiaohong Mary Zhang
Journal:  Cell Death Dis       Date:  2020-05-07       Impact factor: 9.685

9.  USP32 promotes tumorigenesis and chemoresistance in gastric carcinoma via upregulation of SMAD2.

Authors:  Ning Dou; Qingqing Hu; Li Li; Qiong Wu; Yandong Li; Yong Gao
Journal:  Int J Biol Sci       Date:  2020-03-12       Impact factor: 6.580

Review 10.  The role of ubiquitination and deubiquitination in cancer metabolism.

Authors:  Tianshui Sun; Zhuonan Liu; Qing Yang
Journal:  Mol Cancer       Date:  2020-10-01       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.